Company Filing History:
Years Active: 1996-2009
Title: June R Eisenman: Innovator in Cancer Treatment and Biotechnology
Introduction
June R Eisenman is a prominent inventor based in Seattle, WA (US). She has made significant contributions to the field of biotechnology, particularly in cancer treatment and gastrointestinal diseases. With a total of 8 patents to her name, her work has had a profound impact on medical science.
Latest Patents
Eisenman's latest patents include groundbreaking methods for treating cancer by administering an epithelium-derived T-cell factor. These patents disclose nucleic acid sequences that encode biologically active ETF, expression vectors that direct the expression of ETF, ETF polypeptides, and antibodies that specifically bind ETF. Additionally, the patents outline processes for preparing these components and methods for treating or preventing gastrointestinal diseases and HIV or HIV-associated diseases.
Career Highlights
Throughout her career, June R Eisenman has worked with notable companies such as Immunex Corporation and Amgen Inc. Her innovative approaches and research have positioned her as a leader in her field, contributing to advancements in therapeutic methods and biotechnology.
Collaborations
Eisenman has collaborated with esteemed colleagues, including Kenneth H Grabstein and Dirk M Anderson. These partnerships have further enhanced her research and development efforts, leading to significant advancements in her areas of expertise.
Conclusion
June R Eisenman is a trailblazer in the field of biotechnology, with a focus on cancer treatment and innovative medical solutions. Her contributions continue to influence the landscape of medical research and therapy.